Dimensional Fund Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$304M Buy
1,089,323
+12,251
+1% +$3.53M 0.06% 350
2025
Q4
$326M Buy
1,077,072
+14,134
+1% +$4.41M 0.07% 304
2025
Q3
$298M Buy
1,062,938
+63,370
+6% +$17.2M 0.06% 333
2025
Q2
$241M Buy
999,568
+122,528
+14% +$29M 0.06% 408
2025
Q1
$214M Buy
877,040
+130,921
+18% +$39.4M 0.05% 431
2024
Q4
$245M Buy
746,119
+91,690
+14% +$31.1M 0.06% 380
2024
Q3
$219M Buy
654,429
+159,825
+32% +$50.8M 0.05% 436
2024
Q2
$135M Buy
494,604
+193,700
+64% +$56.3M 0.04% 703
2024
Q1
$104M Buy
300,904
+81,334
+37% +$26.7M 0.03% 916
2023
Q4
$70.9M Sell
219,570
-402
-0.2% -$126K 0.02% 1184
2023
Q3
$78.8M Buy
219,972
+15,966
+8% +$6.16M 0.03% 997
2023
Q2
$77.3M Buy
204,006
+15,607
+8% +$6.35M 0.02% 1025
2023
Q1
$90.2M Buy
188,399
+2,265
+1% +$1.06M 0.03% 895
2022
Q4
$78.3K Buy
186,134
+2,920
+2% +$1.18M 0.02% 957
2022
Q3
$76.4M Buy
183,214
+4,635
+3% +$2.31M 0.03% 893
2022
Q2
$88.4M Buy
178,579
+1,439
+0.8% +$749K 0.03% 835
2022
Q1
$99.8M Buy
177,140
+216
+0.1% +$130K 0.03% 852
2021
Q4
$134M Buy
176,924
+1,629
+0.9% +$1.22M 0.04% 643
2021
Q3
$131M Sell
175,295
-2,095
-1% -$1.57M 0.04% 612
2021
Q2
$114M Buy
177,390
+3,563
+2% +$2.17M 0.04% 735
2021
Q1
$99.3M Buy
173,827
+5,897
+4% +$3.49M 0.03% 836
2020
Q4
$97.9M Buy
167,930
+700
+0.4% +$399K 0.04% 762
2020
Q3
$86.2M Buy
167,230
+1,740
+1% +$881K 0.04% 706
2020
Q2
$74.7M Buy
165,490
+4,640
+3% +$2.05M 0.03% 797
2020
Q1
$56.4M Sell
160,850
-15,131
-9% -$5.56M 0.03% 914
2019
Q4
$65.1M Sell
175,981
-7,105
-4% -$2.5M 0.02% 1170
2019
Q3
$60.9M Sell
183,086
-15,461
-8% -$5.04M 0.02% 1196
2019
Q2
$62.1M Sell
198,547
-42,573
-18% -$12.7M 0.02% 1189
2019
Q1
$73.7M Buy
241,120
+20,276
+9% +$5.47M 0.03% 958
2018
Q4
$51.3M Buy
220,844
+30,185
+16% +$8.1M 0.02% 1214
2018
Q3
$59.7M Buy
190,659
+16,674
+10% +$5.18M 0.02% 1262
2018
Q2
$50.2M Sell
173,985
-2,077
-1% -$573K 0.02% 1419
2018
Q1
$44M Sell
176,062
-8,258
-4% -$2.1M 0.02% 1475
2017
Q4
$44M Sell
184,320
-22,644
-11% -$5.49M 0.02% 1491
2017
Q3
$46M Sell
206,964
-15,236
-7% -$3.43M 0.02% 1384
2017
Q2
$50.3M Sell
222,200
-50,802
-19% -$11.1M 0.02% 1232
2017
Q1
$54.4M Buy
273,002
+1,887
+0.7% +$363K 0.03% 1093
2016
Q4
$49.4M Sell
271,115
-5,728
-2% -$977K 0.02% 1135
2016
Q3
$45.3M Buy
276,843
+6,685
+2% +$1.01M 0.02% 1145
2016
Q2
$38.6M Buy
270,158
+843
+0.3% +$120K 0.02% 1246
2016
Q1
$36.8M Buy
269,315
+9,695
+4% +$1.27M 0.02% 1258
2015
Q4
$36M Buy
259,620
+10,154
+4% +$1.41M 0.02% 1200
2015
Q3
$33.5M Buy
249,466
+5,182
+2% +$746K 0.02% 1220
2015
Q2
$36.8M Buy
244,284
+11,364
+5% +$1.63M 0.02% 1207
2015
Q1
$31.5M Buy
232,920
+53,929
+30% +$6.68M 0.02% 1331
2014
Q4
$21.6M Buy
178,991
+32,006
+22% +$3.68M 0.01% 1666
2014
Q3
$16.7M Buy
146,985
+2,272
+2% +$269K 0.01% 1815
2014
Q2
$17.3M Buy
144,713
+16,297
+13% +$1.99M 0.01% 1788
2014
Q1
$16.4M Sell
128,416
-107
-0.1% -$13.7K 0.01% 1762
2013
Q4
$15.9M Buy
128,523
+12,484
+11% +$1.52M 0.01% 1764
2013
Q3
$13.6M Buy
116,039
+7,370
+7% +$869K 0.01% 1825
2013
Q2
$12.2M Buy
+108,669
New +$12.7M 0.01% 1833

Other funds holding BIO